MphasiS Limited (MPHASIS)
Analysts/Institutional Investor Meet/Con. Call Updates
AI summary
- Q1 FY27 revenue $471M, +2.1% sequential, +8.3% YoY constant currency
- Pipeline grew 8% sequentially, 28% YoY; AI-led deals now 70% of pipeline
- Net new TCV $461M in Q1; three large deals including one >$100M
- FY27 guidance maintained: high single-digit to low double-digit growth, EBIT margin 14.75%-15.75%
- Margin impacted by ramp-up costs and TAP acquisition; expected normalization over year
- BFS segment grew 9.4% YoY; Insurance and TMT strong growth drivers
- Platform Mphasis Tria™ gaining traction with faster deal closures and recurring revenue
- Client base expanding with wallet-share gains; top 11-30 accounts grew 21% YoY
- Competitive intensity rising; focus on AI deployment and outcome-based pricing
- Operating cash flow conversion expected ~80% of net income in FY27
Source: Original filing PDF
—
view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts
BOT
🚨 MPHASIS — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
Instant audio summaries2-min AI concall recap delivered with every earnings alert
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes
Add MPHASIS to your watchlist — all of this, automated.
Sign in with Google14-day Pro trial · No credit card · Cancel anytime
More on MphasiS Limited
Important.
The summary above is generated automatically from MphasiS Limited's own
public regulatory filing under SEBI LODR. Indian Stock Alerts is
not a SEBI-registered Research Analyst or Investment Adviser.
This page is informational, not investment advice, a recommendation to buy
or sell any security, or any opinion about the company's business, governance
or financial health. Always read the original filing before acting and consult
a registered adviser for investment decisions.